Clinical Study

Efficacy of Tumor-Infiltrating Lymphocytes Combined with IFN-α in Chinese Resected Stage III Malignant Melanoma

Figure 1

(a) The proportion of CD3+ T cells among TIL cells. (b) The proportion of CD3+CD4+ and CD3+CD8+ T cells among TIL cells. (c) The proportion of CD45+ T cells among TIL cells. (d) The proportion of CD3−CD16+CD56+ T cells among TIL cells.
(a)
(b)
(c)
(d)